We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Cardiology

Cardiology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

AI-Enhanced ECG Screening Pinpoints Atrial Fibrillation Risk in Older Adults: Key Insights from VITAL-AF Trial
Cardiologyartificial intelligenceatrial fibrillation

AI-Enhanced ECG Screening Pinpoints Atrial Fibrillation Risk in Older Adults: Key Insights from VITAL-AF Trial

By MedXY|Apr 15, 2026

A VITAL-AF trial analysis reveals that combining ECG-based artificial intelligence with clinical risk scores significantly improves atrial fibrillation screening efficiency. The study demonstrates that high-risk individuals benefit most fro

Exercise Unmasks Multi-Organ Deficits That Predict Heart Failure Risk: Metabolite Signatures Reveal Shared Pathways Across HFpEF and Its Comorbidities
Cardiologycardiopulmonary exercise testingheart failure

Exercise Unmasks Multi-Organ Deficits That Predict Heart Failure Risk: Metabolite Signatures Reveal Shared Pathways Across HFpEF and Its Comorbidities

By MedXY|Apr 15, 2026

A landmark study reveals that exercise-induced multi-organ physiologic deficits strongly predict incident heart failure with preserved ejection fraction (HFpEF). Using invasive cardiopulmonary testing, metabolomics, and genomics across over

Longer Wait, Higher Risk? How Timing of Hypertensive Disorder Diagnosis Shapes Women’s Cardiovascular Future
Cardiologycardiovascular riskexpectant management

Longer Wait, Higher Risk? How Timing of Hypertensive Disorder Diagnosis Shapes Women’s Cardiovascular Future

By MedXY|Apr 14, 2026

New research reveals that longer latency between hypertensive disorder of pregnancy diagnosis and delivery correlates with subtle inflammatory and lipid changes in young mothers, suggesting subclinical cardiovascular risk elevation years af

Biological Age Outpaces Chronological Age in Predicting Cerebral Small Vessel Disease Progression
Cardiologybiological agingcognitive decline

Biological Age Outpaces Chronological Age in Predicting Cerebral Small Vessel Disease Progression

By MedXY|Apr 14, 2026

This longitudinal cohort study reveals that biomarker-based biological age, particularly KDMAge and PhenoAge residuals, significantly predicts progression of cerebral small vessel disease, including new lacunes and microbleeds, offering pot

Mavacamten Achieves Surgical-Grade Hemodynamic Correction in Obstructive Hypertrophic Cardiomyopathy by Reversing the Anrep Response
Cardiologyalcohol septal ablationAnrep response

Mavacamten Achieves Surgical-Grade Hemodynamic Correction in Obstructive Hypertrophic Cardiomyopathy by Reversing the Anrep Response

By MedXY|Apr 13, 2026

A comparative pressure-volume analysis reveals that mavacamten and alcohol septal ablation produce equivalent hemodynamic improvements in obstructive HCM, primarily through reversal of the chronic Anrep response that drives elevated myocard

Ticagrelor Falls Short: TUXEDO-2 Trial Challenges Antiplatelet Choice in Diabetic Patients With Multivessel Disease
CardiologydiabetesMultivessel Coronary Artery Disease

Ticagrelor Falls Short: TUXEDO-2 Trial Challenges Antiplatelet Choice in Diabetic Patients With Multivessel Disease

By MedXY|Apr 13, 2026

The TUXEDO-2 trial reveals that ticagrelor did not meet noninferiority criteria compared with prasugrel in diabetic patients with multivessel coronary artery disease undergoing PCI. At 1 year, the primary composite endpoint of death, MI, st

Why Exercise Blood Pressure Alone May Miss Cardiovascular Risk—and What Combining It With Fitness Reveals
Cardiologyaerobic fitnesscardiovascular risk

Why Exercise Blood Pressure Alone May Miss Cardiovascular Risk—and What Combining It With Fitness Reveals

By MedXY|Apr 13, 2026

The EXERTION study of 12,743 individuals demonstrates that exercise systolic blood pressure relative to aerobic fitness (SBP/METPeak) is a powerful predictor of cardiovascular events, whereas exercise BP alone provides no prognostic value.

Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions: EUROCTO and DECISION-CTO Meta-Analysis
Cardiologyanginachronic total occlusion

Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions: EUROCTO and DECISION-CTO Meta-Analysis

By MedXY|Apr 13, 2026

A pooled analysis of EUROCTO and DECISION-CTO trials found PCI significantly improved quality of life, angina frequency, and SAQ scores compared to medical therapy for patients with chronic total coronary occlusions, with no increased risk

Mobile Health Intervention Achieves 24% Better Blood Pressure Control in Stroke Survivors: PINGS Trial Results from Ghana
CardiologyBlood Pressure ControlHypertension

Mobile Health Intervention Achieves 24% Better Blood Pressure Control in Stroke Survivors: PINGS Trial Results from Ghana

By MedXY|Apr 13, 2026

The PINGS trial demonstrates that a 12-month nurse-led mobile health intervention significantly improves blood pressure control among Ghanaian stroke survivors, with 67% achieving target BP versus 43% in usual care. This pragmatic approach

Efficacy of Blood Pressure-Lowering Pharmacotherapy in Isolated Diastolic Hypertension: A Systematic Synthesis of Evidence
CardiologyBP Loweringcardiovascular risk

Efficacy of Blood Pressure-Lowering Pharmacotherapy in Isolated Diastolic Hypertension: A Systematic Synthesis of Evidence

By MedXY|Apr 13, 2026

This review synthesizes recent evidence, including a landmark 2026 meta-analysis, showing that blood pressure-lowering therapy provides similar cardiovascular benefits in patients with isolated diastolic hypertension compared to those with

Blood Eosinophil Count at COPD Exacerbation Predicts Long-Term Cardiovascular Risk: A Retrospective Cohort Study
Cardiologybiomarkercardiovascular events

Blood Eosinophil Count at COPD Exacerbation Predicts Long-Term Cardiovascular Risk: A Retrospective Cohort Study

By MedXY|Apr 11, 2026

A large retrospective cohort study of 143,517 patients reveals that non-eosinophilic acute exacerbations of COPD carry a significantly higher one-year risk of major adverse cardiovascular events compared with eosinophilic exacerbations, sug

Teleneurological Ward Rounds Outperform On-Site Consultations in Subacute Stroke Care: A Prospective Multicenter Study
Cardiologyguideline adherencestroke care

Teleneurological Ward Rounds Outperform On-Site Consultations in Subacute Stroke Care: A Prospective Multicenter Study

By MedXY|Apr 7, 2026

A prospective multicenter study demonstrates that teleneurological ward rounds achieve 92% guideline adherence versus 54% for on-site consultations in subacute stroke care, with superiority across all quality domains and most pronounced ben

Genetic Risk Scores and Postpartum Hypertension: Integrating Polygenic Insight with Clinical Risk Stratification
CardiologyHypertensive Disorders of Pregnancypolygenic risk score

Genetic Risk Scores and Postpartum Hypertension: Integrating Polygenic Insight with Clinical Risk Stratification

By MedXY|Apr 9, 2026

This review explores how polygenic risk scores and clinical factors like BMI and pregnancy history predict incident hypertension 2 to 7 years post-delivery, highlighting the dominance of modifiable risk factors over genetic predisposition.

LBBP Matches BiVP in ECG Metrics but Excels at Cellular Level: Canine Study Redefines Cardiac Resynchronization Therapy
CardiologyBiventricular pacingCanine model

LBBP Matches BiVP in ECG Metrics but Excels at Cellular Level: Canine Study Redefines Cardiac Resynchronization Therapy

By MedXY|Apr 6, 2026

A canine study reveals left bundle branch pacing achieves equivalent QRS narrowing and ejection fraction improvement as biventricular pacing, yet demonstrates superior recovery of cardiac mechanics, calcium handling, and energy metabolism a

Apolipoprotein C-III Inhibition and the Atherosclerosis Paradox: Lessons from the Essence-TIMI 73b Olezarsen Study
CardiologyatherosclerosisCardiology

Apolipoprotein C-III Inhibition and the Atherosclerosis Paradox: Lessons from the Essence-TIMI 73b Olezarsen Study

By MedXY|Apr 9, 2026

The Essence-TIMI 73b trial reveals that despite a 64% reduction in triglycerides and a 72% drop in remnant cholesterol via olezarsen, non-calcified coronary plaque volume remained unchanged over 12 months.

Timing of Atrial Fibrillation Diagnosis Does Not Alter Early Anticoagulation Benefits in Stroke Patients: Insights from the OPTIMAS Trial
Cardiologyanticoagulationatrial fibrillation

Timing of Atrial Fibrillation Diagnosis Does Not Alter Early Anticoagulation Benefits in Stroke Patients: Insights from the OPTIMAS Trial

By MedXY|Apr 5, 2026

Subgroup analysis of the OPTIMAS trial reveals that neither the timing of atrial fibrillation diagnosis nor AF subtype modifies the treatment effect of early versus delayed direct oral anticoagulant initiation in acute ischemic stroke. Pers

Timing Extubation After Thrombectomy: Evidence from the EDESTROKE Trial and Advanced Post-Reperfusion Management
CardiologyExtubationischemic stroke

Timing Extubation After Thrombectomy: Evidence from the EDESTROKE Trial and Advanced Post-Reperfusion Management

By MedXY|Apr 5, 2026

The EDESTROKE trial finds no significant difference in 90-day functional outcomes between early (<6h) and delayed (6-12h) extubation post-thrombectomy, shifting focus toward microvascular and hemodynamic optimization.

Decoding the Heart Failure Peptidome: A Cross-Sectional Study Uncovers Novel Biomarkers and Patient Clusters
Cardiologybiomarkersheart failure

Decoding the Heart Failure Peptidome: A Cross-Sectional Study Uncovers Novel Biomarkers and Patient Clusters

By MedXY|Apr 5, 2026

A groundbreaking mass spectrometry study analyzing 486 heart failure patients and 98 controls identified over 21,000 unique peptides, revealing 1,924 differentially expressed peptides. The research highlights angiotensin-related peptides, n

Only 1 in 5 Veterans with Heart Failure Achieve Recommended Quadruple Therapy Within 3 Years—What This Means for Clinical Practice
CardiologyGDMThealth equity

Only 1 in 5 Veterans with Heart Failure Achieve Recommended Quadruple Therapy Within 3 Years—What This Means for Clinical Practice

By MedXY|Apr 5, 2026

A large retrospective study of 52,850 veterans reveals that just 21.2% achieve guideline-directed quadruple therapy for HFrEF, with a median time of 197 days. Socioeconomic barriers, including prescription copays, emerge as critical modifia

Redefining the Renin-Aldosterone Axis: From Categorical Diagnosis to a Continuous Spectrum of Cardiorenal Risk
Cardiologycardiorenal syndromeHypertension

Redefining the Renin-Aldosterone Axis: From Categorical Diagnosis to a Continuous Spectrum of Cardiorenal Risk

By MedXY|Apr 5, 2026

This article synthesizes evidence from a 2026 Danish nationwide cohort and supporting literature, illustrating that renin-independent aldosterone production represents a continuous risk gradient for kidney failure and MACE, even below tradi

Prev
25 / 25
1…232425
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles